Post-menopausal hormone therapy reduces autoantibodies to oxidized apolipoprotein B100

References

• Kannel WB. Metabolic risk factors for coronary artery disease in women: prospective from the Framingham study. Am Heart J 1987;114:413–419.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447–452.
   PubMed Web of Science ®Google Scholar
• Manson JE. Postmenopausal hormone therapy and atherosclerotic disease. Am Heart J 1994;128:1337–1343.
   PubMed Web of Science ®Google Scholar
• Mesalić L, Tupković E, Kendić S, Balić D. Correlation between hormonal and lipid status in women in menopause. Bosn J Basic Med Sci 2008;8:188–192.
   Google Scholar
• Wakatsuki A, Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol 1995;85:523–528.
   PubMed Web of Science ®Google Scholar
• Walsh B, Li H, Sacks F. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res 1994;35:2083–2093.
   PubMed Web of Science ®Google Scholar
• Zambon A, Hokanson JE, Brown BG, Brunzell JD. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 1999;99:19–59.
   Google Scholar
• Lagrost L, Desrumaux C, Masson D, Deckert V, Gambert P. Structure and function of the plasma phospholipids transfer protein. Curr Opin Lipidol 1998;9: 2033–2209.
   Google Scholar
• Lewis-Barned NJ, Sutherland WH, Walker RJ, Walker HL, De Jong SA, Edwards EA, Markham VH. Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. J Clin Endocrinol Metab 1999;84:3534–3538.
   PubMed Web of Science ®Google Scholar
• Zang C, Zhuang Y, Qiang H, Liu X, Xu R, Wu Y. Relationship between endogenous estrogen concentrations and serum cholesteryl ester transfer protein concentrations in Chinese women. Clin Chim Acta 2001;314: 77–83.
   Google Scholar
• Barter P. CETP and atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:2029–2031.
   PubMed Web of Science ®Google Scholar
• Yatsuya H. Serum phospholipids transfer protein mass as a possible protective factor for coronary heart diseases. Circ J 2004;68:11–16.
   Google Scholar
• Berg GA, Siseles N, González AI, Ortiz OC, Tempone A, Wikinski RW. Higher values of hepatic lipase activity in post menopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause 2001;8:51–57.
   PubMed Web of Science ®Google Scholar
• Halperin H, Berg G, Aisemberg L, Brites F, Siseles N, Wikinski R. Intermediate-density lipoproteins and liver lipase in postmenopausal women. Medicina (B Aires) 1992;52:213–219.
   Google Scholar
• Yla-Herttuala S, Luoma J, Kallionpää H, Laukkanen M, Lehtolainen P, Viita H. Pathogenesis of atherosclerosis. Maturitas 1996;9:23–47.
   Google Scholar
• Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol 1997;20:426–432.
   PubMed Web of Science ®Google Scholar
• Heikkinen AM, Ylä-Herttuala S, Luoma J, Tuppurainen MT, Komulainen M, Saarikoski S. Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL. Maturitas 1998;29:155–161.
   PubMedGoogle Scholar
• Ketelhuth DFJ, Boschcov P, Carvalho MDT, Gidlund M. Separation of low-density lipoprotein (LDL) and oxidized LDL (oxLDL) subspecies and reactivity against autoantibodies. Revista da Sociedade Brasileira de Medicina Tropical 2001;34:72–78.
   Google Scholar
• Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G, Celotta G, Cassibba N, Pennisi G, Caschetto S. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 2006;53:77–82.
   PubMed Web of Science ®Google Scholar
• Bureau I, Laporte F, Favier M, Faure H, Fields M, Favier AE, Roussel AM. No antioxidant effect of combinated HTR on oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Choll Nutr 2002;21:333–338.
   PubMed Web of Science ®Google Scholar
• Byington RP, Furberg CD, Herrington DM, Herd JA, Hunninghake D, Lowery M, Riley W, Craven T, Chaput L, Ireland CC, Applegate WB. Heart and Estrogen/Progestin Replacement Study Research Group. Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy. Arterioscler Thromb Vasc Biol 2002;22:1692–1697.
   PubMed Web of Science ®Google Scholar
• Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D. Estrogen replacement therapy and progression of intimae-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol 1995;142:1011–1019.
   PubMed Web of Science ®Google Scholar
• Hodis HN, St John JA, Xiang M, Cushman M, Lobo RA, Mack WJ. Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial). Am J Cardiol 2008;101:1131–1133.
   PubMed Web of Science ®Google Scholar
• Griewing B, Römer T, Spitzer C, Lüdemann J, Günther A, Kessler C. Hormone replacement therapy in postmenopausal women: carotid intima-media thickness and 3-D volumetric plaque quantification. Maturitas 1999;32:33–40.
   Google Scholar
• Takahashi K, Tanaka E, Murakami M, Mori-Abe A, Kawagoe J, Takata K, Ohmichi M, Kurachi H. Long-term hormone replacement therapy delays the age related progression of carotid intima-media thickness in healthy postmenopausal women. Maturitas 2004;49:170–177.
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, et al. Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003;349:535–545.
   PubMed Web of Science ®Google Scholar
• Ettinger B, Woods NF, Barrett-Connor E, Pressman A. The North American Menopause Society 1998 menopause survey. II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care. Menopause 2000;7:143–148.
   Google Scholar
• Ehhnholm C, Kuusi T. Preparation, characterization and measurement of hepatic lipase. Methods Enzymol 1986;129: 7716–7738.
   Google Scholar
• Gidlund M, Damasceno NR, Lindoso JA, Abdalla DS and Goto H. Monoclonal antibodies against low density lipoprotein with various degrees of oxidative modifications. Braz J Med Res 1996;29:1625–1628.
   Google Scholar
• Damasceno NR, Goto H, Rodrigues FM, Dias CT, Okawabata FS, Abdalla DS, Gidlund M. Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. J Nutr 2000;130:2641–2647.
   Google Scholar
• Boschcov P, Juliano L, Juliano MA, Gidlund M. Development of a peptide-based ELISA for the detection of antibodies against oxidized low density lipoprotein (oxLDL). Atherosclerosis 2000;151:224–28.
   Google Scholar
• Lagrost L. Determination of the mass concentration and the activity of the plasma cholesteryl ester transfer protein (CETP). Methods Mol Biol 1998;110:231–241.
   Google Scholar
• Damen J, Regts J, Scherphof G. Transfer of [14C] phosphatidylcholine between liposome and human plasma high density lipoprotein partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta 1982;712:444–452.
   PubMedGoogle Scholar
• Akcay T, Dinçer Y, Kayali R, Colgar U, Oral E, Cakatay U. Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women. J Toxicol Environ Health A 2000;59:1–5.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005;3:28–67.
   PubMed Web of Science ®Google Scholar
• Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G, Celotta G, Cassibba N, Pennisi G, Caschetto S. Behaviour of some indicators of oxidative stress in posmenopausal and fertile women. Maturitas 2001;38:165–170.
   Google Scholar
• Mittal PC, Kant R. Role of free radicals in menopausal distress. J Clin Diag Res 2005;3:28–67.
   Google Scholar
• Uint L, Gebara OC, Pinto LB, Wajngarten M, Boschcov P, da Luz PL, Gidlund M. Hormone replacement therapy increases levels of antibodies against heat shock protein 65 and certain species of oxidized low density lipoprotein. Braz J Med Biol Res 2003;36:491–494.
   Google Scholar
• Hoogerbrugge N, Zillikens MC, Jansen H, Meeter K, Deckers JW, Birkenhäger JC. Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease. Metabolism 1998;47:675–680.
   PubMed Web of Science ®Google Scholar
• McNamara JR, Jenner JL, Li Z, Wilson PW, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992;12:1284–1290.
   PubMedGoogle Scholar
• Lassila HC, Tyrrell KS, Matthews KA, Wolfson SK, Kuller LH. Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke 1997;28:513–517.
   PubMed Web of Science ®Google Scholar
• Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998;29:1116–1121.
   PubMed Web of Science ®Google Scholar
• Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001;32:1104–1111.
   PubMed Web of Science ®Google Scholar
• Le Gal G. Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study. Atherosclerosis 2003;166:163–170.
   PubMed Web of Science ®Google Scholar
• Karim R, Mack WJ, Lobo RA, Hwang J, Liu CR, Liu CH, Sevanian. Determinants of the effects of estrogen on the progress of subclinical atherosclerosis: estrogen in the prevention of atherosclerosis trial. Menopause 2005;12: 357–358.
   Google Scholar
• Naessen T, Rodriguez-Macias K. Menopausal estrogen therapy counteracts normal aging effects on intima thickness, media thickness and intima/media ratio in carotid and femoral arteries. An investigation using noninvasive high-frequency ultrasound. Atherosclerosis 2006;189:387–392.
   Google Scholar
• Somunkiran A, Yazici B, Demirci F, Erdogmus B, Ozdemir. Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause. Climacteric 2006;9:59–65.
   PubMed Web of Science ®Google Scholar
• Byington RF. Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy. Arterioscler Thromb Vasc Biol 2002;22:1692–1697.
   PubMed Web of Science ®Google Scholar
• Campos H, McNamara JR, Wilson PW, Ordovas JM, Schaefer EJ. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988;67:30–35.
   PubMed Web of Science ®Google Scholar
• Tikkanen MJ, et al. Effects of oestradiol and levonorgestrol on lipoprotein lipids and post-heparin plasma lipase activities in normolipoproteinemic women. Acta Endocrinol 1982;99: 630–635.
   Google Scholar
• Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996;16:523–528.
   Google Scholar
• Halperin H, et al. Intermediate-density lipoproteins and liver lipase in postmenopause women. Medicina (B Aires) 1992;52: 213–219.
   Google Scholar
• Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993;13:147–153.
   PubMed Web of Science ®Google Scholar
• Tilly-Kiesi M. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. Atherosclerosis 1997;129:249–259.
   Google Scholar
• Mahmud K. Natural hormone therapy for menopause. Gynecol Endocrinol 2009;8:1–5.
   Google Scholar